DDrare: Database of Drug Development for Rare Diseases

212. 三尖弁閉鎖症
［臨床試験数：6，薬物数：8（DrugBank：7），標的遺伝子数：8，標的パスウェイ数：12］

Searched query = "Tricuspid atresia", "TA"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Bosentan; Device: Methacetin Breath Test (MBT); Dexmedetomidine; Liothyronine; Liothyronine I 131; MBT; Sildenafil; Vitamin C

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00004828 (ClinicalTrials.gov)	December 1994	24/2/2000	Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure		Tricuspid Atresia;Heart Defects, Congenital	Drug: liothyronine I 131	FDA Office of Orphan Products Development	Children's Hospital and Health Center	Completed	N/A	17 Years	Both	28	Phase 1	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00004828
(ClinicalTrials.gov)

December 1994

24/2/2000

Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure

Tricuspid Atresia;Heart Defects, Congenital

Drug: liothyronine I 131

FDA Office of Orphan Products Development

Children's Hospital and Health Center

Completed

N/A

17 Years

Both

Phase 1

NULL